AGP says Counterfeit Azomax triggered misleading safety concerns
AGP Limited (PSX: AGP) moved to reassure investors after reports linking its flagship antibiotic Azomax to quality concerns stemmed from a counterfeit product rather than medicine manufactured by the company.
July 17, 2026 (MLN): AGP Limited (PSX: AGP) moved to reassure investors after reports linking its flagship antibiotic Azomax to quality concerns stemmed from a counterfeit product rather than medicine manufactured by the company. The drugmaker said a Punjab Directorate of Drugs Control alert issued on July 8 referred to a fake Azomax (Azithromycin) batch recovered from an unauthorized source rather...